|
|
|
Past Dev ExperienceOur team members have handled global trials in the following therapeutic areas:
- Oncology: (small and big molecules)
- Glioma (IND, phase I/II)
- Colorectal Cancer (Phase II)
- Sarcoma (Phase II)
- Breast Cancer (Phase II/III)
- Melanoma (IND, Phase I)
- Chemotherapy-Induced Neuropathy (Phase III)
- Radiation or Chemotherapy Induced Fatigue (Phase II)
- Cardiovascular/Peripheral Vascular (small molecules)
- Heart Failure (IND, Phase I/IIa)
- Acute Myocardial Infarction (Phase III)
- Intermittent Claudication (Phase III/NDA)
- Others
- End Stage Renal Disease (Phase III)
- Attention Deficit and Hyper Active Disorder (Phase II)
- Diabetic Peripheral Poly-neuropathy (Phase III)
We have also conduct clinical development projects to the Chinese SFDA:
- Oncology: small molecules
- Breast cancer (Phase III)
- Hepatoma (IND, Phase II)
- Non Small-Cell Lung Cancer (Phase IIIb)
- Cardiovascular
- AMI (“IND”, phase IIIs)
- Hypertension (Phase III)
- Anti-Inflammatory
- Rheumatoid Arthritis / Oesteoarthritis (Phase III and Phase IIIb)
- Anti-Infectious
- HIV expanded access trial
- HBV (Phase III)
- Antibiotics (Phase I)
- Reproductive Health
- Family planning (Ru486 Phase III; Depo Provera clinical verification trial and health economics studies)
|
Fountain will exhibit at both ASCO and DIA Annual Meetings next month